| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0024-3205(75)90299-4 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0024320575902994?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0024320575902994?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 168452 |
| P2093 | author name string | H. O. Collier | |
| A. C. Roy | |||
| D. L. Francis | |||
| P2860 | cites work | Hypothesis: Inhibition of E prostaglandin-sensitive adenyl cyclase as the mechanism of morphine analgesia | Q39902708 |
| Morphine abstinence is associated with increased brain cyclic AMP | Q39929603 | ||
| The relation of adenyl cyclase to the activity of other ATP utilizing enzymes and phosphodiesterase in preparations of rat brain; mechanism of stimulation of cyclic AMP accumulation by NaF. | Q41840758 | ||
| The assay of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate in biological materials by enzymatic radioisotopic displacement | Q44097540 | ||
| Properties of cyclic 3',5'-nucleotide phosphodiesterase from rat brain | Q44675839 | ||
| The concept of the quasi-abstinence effect and its use in the investigation of dependence mechanisms | Q48603775 | ||
| Brain microsomal protein kinase in the chronically morphinized rat. | Q48741453 | ||
| Cyclic adenosine monophosphate phosphodiesterase in brain: effect on anxiety | Q48772746 | ||
| Quasi morphine-abstinence syndrome | Q53899427 | ||
| Modification of Morphine Withdrawal by Drugs interacting with Humoral Mechanisms: Some Contradictions and their Interpretation | Q59049226 | ||
| Antagonism of morphine by long acting narcotic antagonists | Q68933109 | ||
| Enhancement of nociceptive reactions by naloxone in mice and rats (author's transl) | Q69806988 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1901-1906 | |
| P577 | publication date | 1975-06-01 | |
| 1975-06-15 | |||
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Morphine abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone | |
| P478 | volume | 16 |
| Q46555917 | Activity of the nigro-striatal dopaminergic system during precipitated morphine withdrawal investigated in rats with acute unilateral inactivation of the striatum |
| Q40171073 | Caffeine elicited withdrawal signs in morphine-dependent rhesus monkeys |
| Q55491038 | Cellular site of opiate dependence. |
| Q34249595 | Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3?,5?-monophosphate phosphodiesterase inhibitors |
| Q48853298 | Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain |
| Q48654420 | Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures |
| Q47569719 | Effect of adenosine analogues on the expression of opiate withdrawal in rats |
| Q42240490 | Effect of salbutamol and the PDE-inhibitor RA 642 on the clonidine withdrawal syndrome in rats |
| Q36744714 | Endogenous Opiates—A Progress Report |
| Q40127299 | Endogenous opioid peptides--the enkephalins and endorphins. |
| Q40126164 | Endogenous opioids and cyclic AMP |
| Q39542360 | Inhibition of neuronal firing by opiates: evidence against the involvement of cyclic nucleotides |
| Q28354227 | Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor |
| Q48821917 | Long-term effects of neonatal exposure to isobutylmethylxanthine. II. Attenuation of acute morphine withdrawal in mature rats |
| Q39603018 | Lysergic acid diethylamide antagonizes shaking induced in rats by five chemically different compounds |
| Q41878496 | Manifestations of acute opiate withdrawal contracture in rabbit jejunum after mu-, kappa- and delta-receptor agonist exposure |
| Q40210210 | Mechanism of quasi-morphine withdrawal behaviour induced by methylxanthines |
| Q36095852 | Methyl xanthines, adenosine 3',5'-cyclic monophosphate and the spinal transmission of nociceptive information |
| Q36127881 | Model of opiate dependence in the guinea-pig isolated ileum |
| Q69088770 | Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal |
| Q72425198 | Neurotoxicity of oxyquinolines |
| Q93817690 | OBITUARY |
| Q48617076 | Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. |
| Q40011904 | Proceedings: Stereospecific suppression by opiates of the quasi-morphine abstinence syndrome elicited by 3-isobutyl-l-methylxanthine (IBMX) |
| Q72701844 | Species differences in behavioural effects of rolipram and other adenosine cyclic 3h, 5h-monophosphate phosphodiesterase inhibitors |
| Q40060296 | Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline |
| Q46235675 | The adenosine agonist NECA inhibits intestinal secretion and peristalsis |
| Q39545887 | The attenuation by ? 9-Tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats |
| Q40056688 | The effect of capsaicin on the adenylate cyclase activity of rat brain |
| Q36128665 | The effects of morphine and methionine-enkephalin on the release of purines from cerebral cortex slices of rats and mice |
| Q52243851 | The serotonin2 antagonist ritanserin blocks quasi-morphine withdrawal at a time when mianserin is no longer effective |
| Q72425203 | Vitamin A and cancer |
| Q67019764 | delta9-Tetrahydrocannabinol and the quasi morphine withdrawal syndrome |
Search more.